Literature DB >> 11410674

Folding of the group I intron ribozyme from the 26S rRNA gene of Candida albicans.

Y Zhang1, M J Leibowitz.   

Abstract

Preincubation of the group I intron Ca.LSU from Candida albicans at 37 degrees C in the absence of divalent cations results in partial folding of this intron. This is indicated by increased resistance to T1 ribonuclease cleavage of many G residues in most local helices, including P4-P6, as well as the non-local helix P7, where the G binding site is located. These changes correlate with increased gel mobility and activation of catalysis by precursor RNA containing this intron after preincubation. The presence of divalent cations or spermidine during preincubation results in formation of the predicted helices, as indicated by protection of additional G residues. However, addition of these cations during preincubation of the precursor RNA alters its gel mobility and eliminates the preincubation activation of precursor RNA seen in the absence of cations. These results suggest that, in the presence of divalent cations or spermidine, Ca.LSU folds into a more ordered, stable but misfolded conformation that is less able to convert into the catalytically active form than the ribozyme preincubated without cations. These results indicate that, like the group I intron of Tetrahymena, multiple folding pathways exist for Ca.LSU. However, it appears that the role cations play in the multiple folding pathways leading to the catalytically active form may differ between folding of these two group I introns.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11410674      PMCID: PMC55740          DOI: 10.1093/nar/29.12.2644

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  50 in total

1.  A single-molecule study of RNA catalysis and folding.

Authors:  X Zhuang; L E Bartley; H P Babcock; R Russell; T Ha; D Herschlag; S Chu
Journal:  Science       Date:  2000-06-16       Impact factor: 47.728

2.  Probing the structure of RNAIII, the Staphylococcus aureus agr regulatory RNA, and identification of the RNA domain involved in repression of protein A expression.

Authors:  Y Benito; F A Kolb; P Romby; G Lina; J Etienne; F Vandenesch
Journal:  RNA       Date:  2000-05       Impact factor: 4.942

3.  Characterization of the Tetrahymena ribozyme folding pathway using the kinetic footprinting reagent peroxynitrous acid.

Authors:  S G Chaulk; A M MacMillan
Journal:  Biochemistry       Date:  2000-01-11       Impact factor: 3.162

4.  An optimal Mg(2+) concentration for kinetic folding of the tetrahymena ribozyme.

Authors:  M S Rook; D K Treiber; J R Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

5.  Folding mechanism of the Tetrahymena ribozyme P4-P6 domain.

Authors:  M L Deras; M Brenowitz; C Y Ralston; M R Chance; S A Woodson
Journal:  Biochemistry       Date:  2000-09-12       Impact factor: 3.162

6.  Sequence-specific endoribonuclease activity of the Tetrahymena ribozyme: enhanced cleavage of certain oligonucleotide substrates that form mismatched ribozyme-substrate complexes.

Authors:  A J Zaug; C A Grosshans; T R Cech
Journal:  Biochemistry       Date:  1988-12-13       Impact factor: 3.162

7.  Crystal structure of a group I ribozyme domain: principles of RNA packing.

Authors:  J H Cate; A R Gooding; E Podell; K Zhou; B L Golden; C E Kundrot; T R Cech; J A Doudna
Journal:  Science       Date:  1996-09-20       Impact factor: 47.728

8.  Pentamidine inhibits mitochondrial intron splicing and translation in Saccharomyces cerevisiae.

Authors:  Y Zhang; A Bell; P S Perlman; M J Leibowitz
Journal:  RNA       Date:  2000-07       Impact factor: 4.942

9.  Pentamidine inhibition of group I intron splicing in Candida albicans correlates with growth inhibition.

Authors:  K E Miletti; M J Leibowitz
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

10.  Nucleotide sequence of Aspergillus nidulans mitochondrial genes coding for ATPase subunit 6, cytochrome oxidase subunit 3, seven unidentified proteins, four tRNAs and L-rRNA.

Authors:  R Netzker; H G Köchel; N Basak; H Küntzel
Journal:  Nucleic Acids Res       Date:  1982-08-11       Impact factor: 16.971

View more
  7 in total

1.  Fast formation of the P3-P7 pseudoknot: a strategy for efficient folding of the catalytically active ribozyme.

Authors:  Libin Zhang; Mu Xiao; Chen Lu; Yi Zhang
Journal:  RNA       Date:  2004-12-01       Impact factor: 4.942

2.  Concerted folding of a Candida ribozyme into the catalytically active structure posterior to a rapid RNA compaction.

Authors:  Mu Xiao; Michael J Leibowitz; Yi Zhang
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

3.  Pentamidine inhibits catalytic activity of group I intron Ca.LSU by altering RNA folding.

Authors:  Yi Zhang; Zhijie Li; Daniel S Pilch; Michael J Leibowitz
Journal:  Nucleic Acids Res       Date:  2002-07-01       Impact factor: 16.971

4.  Predicting the secondary structures and tertiary interactions of 211 group I introns in IE subgroup.

Authors:  Zhijie Li; Yi Zhang
Journal:  Nucleic Acids Res       Date:  2005-04-20       Impact factor: 16.971

Review 5.  Endogenous polyamine function--the RNA perspective.

Authors:  Helen L Lightfoot; Jonathan Hall
Journal:  Nucleic Acids Res       Date:  2014-09-17       Impact factor: 16.971

6.  A peripheral element assembles the compact core structure essential for group I intron self-splicing.

Authors:  Mu Xiao; Tingting Li; Xiaoyan Yuan; Yuan Shang; Fu Wang; Shoudeng Chen; Yi Zhang
Journal:  Nucleic Acids Res       Date:  2005-08-12       Impact factor: 16.971

7.  A novel antiviral lncRNA, EDAL, shields a T309 O-GlcNAcylation site to promote EZH2 lysosomal degradation.

Authors:  Baokun Sui; Dong Chen; Wei Liu; Qiong Wu; Bin Tian; Yingying Li; Jing Hou; Shiyong Liu; Juan Xie; Hao Jiang; Zhaochen Luo; Lei Lv; Fei Huang; Ruiming Li; Chengguang Zhang; Yuling Tian; Min Cui; Ming Zhou; Huanchun Chen; Zhen F Fu; Yi Zhang; Ling Zhao
Journal:  Genome Biol       Date:  2020-09-01       Impact factor: 13.583

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.